Content area
Full Text
SAN DIEGO, June 25 /PRNewswire/ -- TargeGen, Inc., a biotechnology company focusing on edema, cardiovascular (ischemic) diseases and cancer, today announced the appointment of Sara A. Courtneidge, Ph.D. to its Scientific Advisory Board.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030430/ TARGEGENLOGO)
Dr. Courtneidge currently serves as Distinguished Scientific Investigator, Signal Regulation and Cancer, at The Van Andel Research Institute in Grand Rapids, MI. Previously, Dr. Courtneidge served...